Accrued Expense	6 Months Ended
Jun. 30, 2011
Accrued Expense	5. Accrued Expense As of June 30, 2011, Current Liabilities included accrued expense of $146,526. R&D expenses related to MD Anderson treating patients in the Phase I clinical trial comprised $50,000 of this amount and expenses for clinical trial monitors represented an additional $5,000. Accrued expenses for travel to suppliers, meetings and conferences totaled approximately $16,000. Expenses of being a public company of approximately $5,000 were accrued for auditors and attorney fees, plus business wire services. Management bonus pool accrual comprises $69,375 of accrued expense as of June 30, 2011.

Accrued Expense

6 Months Ended

Jun. 30, 2011

5. Accrued Expense

As of June 30, 2011, Current Liabilities included accrued expense of $146,526. R&D expenses related to MD Anderson treating patients in the Phase I clinical trial comprised $50,000 of this amount and expenses for clinical trial monitors represented an additional $5,000. Accrued expenses for travel to suppliers, meetings and conferences totaled approximately $16,000. Expenses of being a public company of approximately $5,000 were accrued for auditors and attorney fees, plus business wire services. Management bonus pool accrual comprises $69,375 of accrued expense as of June 30, 2011.